ipo
-
Biologics
Nasdaq Stockholm Welcomes Bonesupport to the Main Market
Stockholm, June 21, 2017 — Nasdaq (Nasdaq: NDAQ) announced that Bonesupport Holding AB (short name: BONEX), a small cap company…
Read More » -
Financial
BioVentus delays $150m IPO
JULY 29, 2016 BY FINK DENSFORD Orthobiologics maker Bioventus postponed its initial public offering which was slated to raise up to…
Read More » -
Financial
Bioventus sets terms on $150m IPO
JULY 19, 2016 BY FINK DENSFORD Orthobiologics maker Bioventus today released terms for its $150 million initial public offering, looking to…
Read More » -
Financial
Bone-Healing Therapies Firm Bioventus Files for IPO
By Frank Vinluan – June 30, 2016 Xconomy Raleigh-Durham — Bioventus, a company that develops treatments that harness the body’s…
Read More » -
Financial
Titan Medical Prices $6m Offering
BY BRAD PERRIELLO Titan Medical (CVE:TMD) today priced an 8.9-million-share offering at about 65¢ per share, saying it plans to use the…
Read More » -
Financial
Ellipse Technologies files for $75M IPO for its magnetically adjustable orthopedic implants
By Nicole Oran Aliso Viejo, Calif.-based Ellipse Technologies has filed for an IPO that could bring in as much as…
Read More » -
Financial
ConforMIS Closes Initial Public Offering
BEDFORD, Mass., July 7, 2015 (GLOBE NEWSWIRE) — ConforMIS, Inc. (NASDAQ:CFMS) announced today the closing of its initial public offering…
Read More » -
Financial
ConforMIS sets terms for $135m IPO
By Brad Perriello ConforMIS today set the terms for its forthcoming initial public offering, saying it plans to float 9 million…
Read More » -
Financial
The bee’s knees: ConforMIS files for a $173 million IPO
ConforMIS, which sells customized joint replacement implants, filed on Friday with the SEC to raise up to $173 million in…
Read More » -
Financial
Vertos Medical raising $12M for lumbar spinal stenosis treatment. So when’s that IPO?
By Meghana Keshavan Southern California devicemaker Vertos Medical has been around a decade, and has a clinically validated treatment for lumbar spinal stenosis.…
Read More » -
Biologics
An unmet need for knees: Biotech Histogenics sets terms for $60 million IPO
Histogenics, a biotech developing a therapy for repairing knee cartilage using its tissue repair platform, announced terms for its IPO…
Read More » -
Financial
Nevro boosts IPO to $126m
MENLO PARK, Calif., Nov. 6, 2014 /PRNewswire/ — Nevro Corp. (NYSE: NVRO), a medical device company that has developed and…
Read More » -
Financial
Nevro sets range for IPO of up to $106m
October 28, 2014 by Brad Perriello Nevro Corp. sets the per-share price range for its pending initial public offering, which…
Read More » -
Financial
Histogenics Files for IPO
Histogenics Corp. has filed its S-1 form with the U.S. Securities and Exchange Commission (SEC) for an initial public offering…
Read More » -
Financial
Nevro registers $100m IPO
October 6, 2014 by Alexander Soule Nevro plans to raise more than $100 million in an initial public offering of…
Read More »